Our closure session, with dr Diaz de Heredia with her fantastic session about the currently situation of #genetherapy and #celltherapies in Spain 👏🏼👏🏼👏🏼💊
#ISSCR2023 was an amazing experience! Leading minds in #stemcell research gathered to share groundbreaking ideas. Our CTO & Director of Genome Engineering talked about #iPSC process development challenges and using #geneediting for off-the-shelf #celltherapies .
Happy to be part of Global StartupCities: Global innovation Area #Ostrava !🤩 We engaged with investors and shared Blood Cancer Research Group vision, research & clinical goals regarding #celltherapies in #bloodcancer . Ostravská univerzita Lékařská fakulta OU FNO
Inspiring presentation by Sonja Schrepfer from UCSF Surgery and Sana Biotechnology in our seminar series this week! She shared exciting progress in the development of hypoimmune cell therapies, including allogeneic islet cell therapy for type I diabetes. #CellTherapies
We are thrilled to share our new development partnership with IASO Biotherapeutics. This will advance two novel off-the-shelf approaches for #CellTherapies and #GeneTherapies to extend their benefits to patients. Read more: brnw.ch/21wFN2d
Wonderful day in #Madrid discussing #celltherapies with colleagues from around the world! Thank you Springer Nature and FundaciónRamónAreces for organizing the symposium!
Unveiling the new visual identity of Cell BioEngines! #offtheshelf #celltherapies to #curecancer IndieBio SOSV - Deep Tech for Human and Planetary Health Stephen Chambers
#Celltherapies are rapidly advancing. With the first-ever approval of an allogeneic #Tcell therapy, cell-based innovation is now a reality. CEO Pascal Touchon shares more. Cell&Gene #CellAndGenePodcast bit.ly/3zKqk8E
Our CEO, Cynthia Pussinen, was featured in a piece from BioPharm Intl detailing Sernova’s expertise on sources of raw material variability and how to approach the resulting challenges in the production of #CellTherapies . Continue reading the article here: brnw.ch/21wFdGL
Full house today at VHIO’s #CancerTalk .
Bringing #science and #society closer together.
Researchers, clinicians, #patients and managers have an open conversation about the challenges & opportunities of #CellTherapies and the expectations and priorities of #cancer patients.
Parse Biosciences announced it has launched its Laboratory Automation Provider Program, enabling automation providers to readily support the adoption of Parse’s Evercode™ single cell products.
tinyurl.com/4vdwu2aw
#automation #celltechnologies #CellTherapies #hamilton #WBO
Spent two hours hearing from our #Immunology team today during a Listening Tour! This team is excellent at team science and is leading the way in clinical and translational research in #CellTherapies . Thanks for taking the time to share your expertise and your progress — and for…
We're excited to announce our new headquarters and manufacturing facility, that will allow us to scale our capabilities for late-stage clinical and commercial supply of our #celltherapies for patients with #autoimmunediseases . Read here: bit.ly/3IqZxCJ
Ever wondered what happened to #celltherapies for #COVID19 ???
🤔🤔🤔
Check out this comprehensive study initiated by Fran & Pedro
👏👏👏
Cell Therapy Clinical Trials ISCT Agência FAPESP Charité - Universitätsmedizin Berlin Berlin Institute of Health Yale University UCL Mesenchymal Cell News #SARSCoV2
👇👇👇
frontiersin.org/articles/10.33…
Speaking with @XTalks, Dominic Borie, MD, PhD, President of R&D shares insights about how we’re shaping the landscape of #celltherapies for #autoimmunedisease .
clinicaledge.xtalks.com/magazine/issue…
Arsenal Biosciences will present 4 posters at the upcoming #ASGCT2024 in Baltimore May 7-10, highlighting our portfolio of #celltherapies in development including #AB1015 and #AB2100 , which are being studied as potential treatments for #ovariancancer and #kidneycancer ,…
Enormous thanks to the industry professionals who joined our 'Biotech Buzz' Careers & Industry Panel last night! Sarah Cox Griffith Hack, Jacob Goodwin Magic Valley, Irene Wong Optiscan, Jennifer Hollands Cell Therapies Pty Ltd, & Andre Tan University of Melbourne RIC. BioSciences UniMelb 👏
Don't miss this episode!
Dr. Lorenz Studer (@StuderL) from Memorial Sloan Kettering Cancer Center talks about the challenges of developing #CellTherapies at scale, strategies to target cognition loss in #Parkinsons , and combining basic and translational research.
Listen now: bit.ly/3XcL3vg
Tune into this week's OIS podcast as Brian Culley of Lineage Cell Therapeutics chats with us about innovative cell therapies & treatment for geographic atrophy & dry AMD.
ois.net/credibility-ca…
#ois #ois podcast #dryamd #celltherapy #celltherapies #ophthalmology #geographicatrophy
